Palvella Therapeutics (PVLA) Payables (2013 - 2026)
Palvella Therapeutics (PVLA) recorded Payables of $6.79 million in Q2 2026, up 48.9% from $4.56 million a year earlier and up 24.7% from the prior quarter.
Powered by 
Analysis
Palvella Therapeutics (PVLA) Payables (2013 - 2026) Analysis & Trends
At the end of FY2025, Palvella Therapeutics reported Payables of $4.6 million, up 0.2% from FY2024.
- Annual Payables has a five-year compound annual growth rate of -9.9% (FY2020 to FY2025).
- Across earlier years, Payables came in at $4.59 million in FY2024 (+390.0%), $936,000 in FY2023 (-77.5%), $4.15 million in FY2022 (-51.7%) and $8.61 million in FY2021 (+11.4%).
- The Q2 2026 figure is the highest quarterly Payables since Q2 2023.
- On a year-over-year basis, Payables has increased for seven consecutive quarters, with growth averaging 160.9% over the last eight quarters.
- Peak year-over-year performance for Payables in the last five years was growth of 390.0% in Q4 2024, against a decline of 87.3% in Q2 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $5.44 million (Q1 2026), $4.6 million (Q4 2025) and $3.48 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Palvella Therapeutics | 2.01 Bn | 1.76 Bn | - | 6.79 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.79 Mn |
| Mar 31, 2026 | 5.44 Mn |
| Dec 31, 2025 | 4.60 Mn |
| Sep 30, 2025 | 3.48 Mn |
| Jun 30, 2025 | 4.56 Mn |
| Mar 31, 2025 | 4.44 Mn |
| Dec 31, 2024 | 4.59 Mn |
| Sep 30, 2024 | 801,000.00 |
| Jun 30, 2024 | 969,000.00 |
| Mar 31, 2024 | 1.52 Mn |
| Dec 31, 2023 | 936,000.00 |
| Sep 30, 2023 | 2.82 Mn |
| Jun 30, 2023 | 7.60 Mn |
| Mar 31, 2023 | 5.83 Mn |
| Dec 31, 2022 | 4.15 Mn |
| Sep 30, 2022 | 3.64 Mn |
| Jun 30, 2022 | 10.79 Mn |
| Mar 31, 2022 | 14.08 Mn |
| Dec 31, 2021 | 8.61 Mn |
| Sep 30, 2021 | 19.69 Mn |
API Access
Palvella Therapeutics Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=PVLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "PVLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=PVLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();